Hua-hao Q. Shen
Second Hospital Of Zhejiang University School Of Medicine. No. 88 Jiefang Road
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
Efficacy of Inhaler Devices in New-Onset Mild Asthma: A Randomized Blinded Multicenter Trial.
Journal: Advances in therapy
Published: March 23, 2025
Effectiveness and safety of Suhuang Zhike capsules in adults with asthma: A multicenter, randomized, double-blinded, placebo-controlled trial.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 22, 2024
TGF-β signaling promotes eosinophil activation in inflammatory responses.
Journal: Cell death & disease
Published: April 10, 2024
Research progress on the pathogenesis of chest tightness variant asthma characterized by chest tightness.
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: February 03, 2024
Rapamycin Exacerbates Staphylococcus aureus Pneumonia by Inhibiting mTOR-RPS6 in Macrophages.
Journal: Journal of inflammation research
Published: August 08, 2023
Airway epithelial cGAS inhibits LPS-induced acute lung injury through CREB signaling.
Journal: Cell death & disease
Published: July 08, 2023
The persistent inflammation in COPD: is autoimmunity the core mechanism?
Journal: European respiratory review : an official journal of the European Respiratory Society
Published: July 06, 2023
CCL11/CCR3-dependent eosinophilia alleviates malignant pleural effusions and improves prognosis.
Journal: NPJ precision oncology
Published: July 03, 2023
Characteristics of serum bile acids among healthy children in Zhejiang province
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: June 14, 2023
Abnormal adenosine metabolism of neutrophils inhibits airway inflammation and remodeling in asthma model induced by Aspergillus fumigatus.
Journal: BMC pulmonary medicine
Published: January 06, 2023
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
Journal: The Lancet. Microbe
Published: January 31, 2022
Last Updated: 09/26/2026